Total revenue from operations grew by 5 per cent y-o-y to ₹202 crore (₹193 crore)

TTK Healthcare posts Q1 net profit of ₹16 crore

Revenue from operations jumps to ₹202 crore from ₹193 crore

TTK Healthcare Q1 net profit from continuing business quadruples

City-based TTK Healthcare Ltd. on Friday said its shares will continue to remain listed on major bourses for trading.

TTK Healthcare shares will continue to be listed

TTK Healthcare’s delisting offer has failed as the total number of shares tendered by public shareholders was less than the 90% minimum requirement. Promoters hold 74.56% of the total 1.41 crore paid-up equity shares while public investors hold 25.44%. Shares trading at ₹1,184 on NSE.

TTK Healthcare says delisting offer failed; shares tendered in buyback to be credited back to public shareholders

Chennai-based TTK Healthcare’s buyback offer to delist its shares from major bourses failed as the number of tendered shares was below the required 90%. Promoters’ shareholding was 87%, short of the statutory requirement. Buyback offer opened on July 20 and closed on July 26 at ₹1,201.30/share. Desp…

TTK Healthcare voluntary delisting offer fails

TTK Healthcare delisting offer fails to draw enough interest; promoters may make counter offer till July 28. Promoters’ 74.56% stake + 17.02 lakh shares tendered by public = 87%, still below 90% delisting requirement. Shares close at ₹1,192.

TTK Healthcare delisting offer fails to interest public shareholders

TTK Healthcare’s delisting offer opens today, ending July 27. Promoters propose to acquire all public equity shares and delist at ₹1,051.31/share, revised to ₹1,201.30. Promoters hold 74.56% of paid-up equity share capital, offering to buy back 25.44% of public equity shareholding. Shares closed at …

TTK Healthcare delisting offer opens today

TTK Healthcare Ltd. has received in-principle approval from major bourses for voluntary delisting of its shares. Promoters have revised exit floor price to ₹1,201.30/share. They have opened an escrow account and deposited ₹432 crore for 36 lakh shares. Delisting to help preserve cash and offer exit …

TTK Healthcare receives BSE, NSE nod for voluntary delisting of shares

TTK Healthcare shares rallied around 6 per cent in early trade after the company revised upwards the floor price for voluntary delisting from the stock exchanges. On Tuesday, the Woodward’s Gripewater maker announced that it revised the floor price for delisting of its shares to ₹1,201.30 per equity…

TTK Healthcare revises delisting floor price, shares rally 6%

Revised buy back price to ₹1,201.30 apiece

TTK Healthcare revises buy back price to ₹1,201.30 apiece

TTK Healthcare revises floor price for delisting to ₹1,201.30

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Strong financials and growth story over the years

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

TTK Healthcare Limited is engaged in pharmaceuticals, consumer products, medical devices and foods businesses.